CROSSJECTFRA:74C +0.12%42 Days Inventory is 118.46 as of Dec. 2025, which is 15% below its 10-year median of 139.57. GuruFocus rates FRA:74C with a GF Score™ of 42/100 and a GF Value™ of €1.11 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 786 Medical Devices & Instruments companies, CROSSJECT ranks better than 70.87% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). CROSSJECT's Average Total Inventories for the
six
months ended in Dec. 2025 was €3.35 Mil. CROSSJECT's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €5.16 Mil.
Hence, CROSSJECT's Days Inventory for the
six
months ended in Dec. 2025 was 118.46.
The historical rank and industry rank for CROSSJECT's Days Inventory or its related term are showing as below:
FRA:74C'
s Days Inventory Range Over the Past 10 Years
Min: 59.63 Med: 139.57 Max: 965.66
Current: 126.69
During the past 13 years, CROSSJECT's highest Days Inventory was 965.66. The lowest was 59.63. And the median was 139.57.
FRA:74C's Days Inventory is ranked better than 70.87% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs FRA:74C: 126.69
CROSSJECT's Days Inventory
declined
from Dec. 2024 (130.22) to Dec. 2025 (118.46).
Inventory Turnover measures how fast the company turns over its inventory within a year.
CROSSJECT's Inventory Turnover for the
six
months ended in Dec. 2025 was 1.54.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CROSSJECT (FRA:74C) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
CROSSJECT's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CROSSJECT's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
CROSSJECT Days Inventory Related Terms
CROSSJECT Days Inventory Historical Data
* Premium members only.
The historical data trend for CROSSJECT's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:74C vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, CROSSJECT's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CROSSJECT Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CROSSJECT's Days Inventory distribution charts can be found below:
* The bar in red indicates where CROSSJECT's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CROSSJECT (FRA:74C) has a Days Inventory of 118.46 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CROSSJECT and its competitors. This is 15% below median its historical median of 139.57. Over the past decade, CROSSJECT's Days Inventory has ranged from 59.63 to 965.66. According to the industry distribution chart, CROSSJECT ranks #229 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 29.1%.
Is CROSSJECT's Days Inventory too high?
CROSSJECT's current Days Inventory of 118.46 is 15% below median its 10-year median of 139.57. Over the past 10 years, this metric has ranged from a low of 59.63 to a high of 965.66. The Medical Devices & Instruments industry median Days Inventory is 179.60. CROSSJECT's value of 118.46 is 34% below this industry median. Based on the distribution chart, CROSSJECT ranks #229 out of 786 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, CROSSJECT has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CROSSJECT's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, CROSSJECT ranks #229 out of 786 companies for Days Inventory. This puts CROSSJECT in the upper half of its industry. The industry median Days Inventory is 179.60. CROSSJECT's value of 118.46 is 34% below this benchmark. Historically, CROSSJECT's own Days Inventory has ranged from 59.63 to 965.66 over the past decade. While the company's 10-year median is 139.57 vs. the industry median of 179.60, CROSSJECT has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CROSSJECT's current Days Inventory of 118.46 is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CROSSJECT and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CROSSJECT's current Days Inventory is 118.46, which is 15% below median its own 10-year median of 139.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CROSSJECT stock overvalued right now?
Based on GuruFocus' analysis, CROSSJECT (FRA:74C) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.11, compared to a current price of €1.66 — trading 49.9% above its estimated fair value. The current Days Inventory is 118.46, which is 15% below median its 10-year median of 139.57 and 34% below the Medical Devices & Instruments industry median of 179.60. CROSSJECT's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For CROSSJECT (FRA:74C), the current Days Inventory is 118.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CROSSJECT (FRA:74C) Overvalued in 2026?
Based on GuruFocus' analysis, CROSSJECT stock appears to be overvalued.
The current stock price of €1.66 is trading 49.9% above its estimated GF Value™ of €1.11.
GuruFocus considers CROSSJECT to be Significantly Overvalued.
Key valuation signals for FRA:74C:
Days Inventory: 118.46 (15% below median its 10-year median of 139.57)
GF Value™: €1.11 vs. price of €1.66 (49.9% above fair value)
Industry Position: 34% below the Medical Devices & Instruments median (#229 of 786)
No single metric tells the full story. See the FRA:74C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:74C has been successfully added to your 
